GLP-1 coverage tracker
GLP-1 Medicaid coverage by US state
Each state Medicaid program decides whether GLP-1 medications (Wegovy, Ozempic, Mounjaro, Zepbound) are covered — and для what indication. Use the tracker below to find your state и see options if denied.
Full
10 states
Limited
35 states
None
5 states
Unknown
0 states
Denied coverage? Options
- • Appeal the denial — most state Medicaid programs allow appeals. Required documentation: prior failed weight-loss attempts, BMI ≥ 30, comorbidities.
- • Switch indications — diabetes diagnosis (vs weight-only) opens Ozempic / Mounjaro coverage в many states even when Wegovy / Zepbound denied.
- • Compounded telehealth — cash-pay $150-300/mo regardless of Medicaid status. See alternatives hub.
- • Manufacturer savings cards— commercial insurance fallback; doesn't apply to Medicaid patients but worth checking eligibility.
Coverage data based on published state Medicaid preferred-drug lists (PDLs). Policies change frequently — verify with your state Medicaid office before relying on this snapshot.